Amsurg Corp. (NASDAQ:AMSG) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest totalling 10,675,274 shares, an increase of 21.9% from the August 31st total of 8,757,733 shares. Approximately 19.9% of the shares of the stock are sold short. Based on an average trading volume of 1,289,022 shares, the short-interest ratio is presently 8.3 days.
AMSG has been the topic of a number of analyst reports. Cantor Fitzgerald reaffirmed a “buy” rating and set a $95.00 price objective on shares of Amsurg Corp. in a research note on Thursday, July 14th. Zacks Investment Research raised Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 price objective on the stock in a research note on Monday, July 11th. Jefferies Group reaffirmed a “buy” rating on shares of Amsurg Corp. in a research note on Sunday, July 3rd. Mizuho increased their price objective on Amsurg Corp. from $90.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, June 24th. Finally, Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Amsurg Corp. in a research note on Friday, June 17th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Amsurg Corp. has a consensus rating of “Buy” and an average target price of $92.55.
Amsurg Corp. (NASDAQ:AMSG) opened at 66.58 on Thursday. Amsurg Corp. has a 12-month low of $58.37 and a 12-month high of $87.29. The stock has a market capitalization of $3.58 billion, a P/E ratio of 19.76 and a beta of 0.65. The stock has a 50 day moving average price of $65.46 and a 200-day moving average price of $73.54.
Amsurg Corp. (NASDAQ:AMSG) last announced its earnings results on Tuesday, August 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.02. The company had revenue of $758.50 million for the quarter, compared to analyst estimates of $769.88 million. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. Amsurg Corp.’s revenue for the quarter was up 21.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.97 earnings per share. Equities research analysts expect that Amsurg Corp. will post $4.33 EPS for the current year.
In related news, insider Robert Jon Coward sold 7,500 shares of the stock in a transaction on Friday, August 26th. The stock was sold at an average price of $63.65, for a total transaction of $477,375.00. Following the sale, the insider now owns 97,507 shares of the company’s stock, valued at $6,206,320.55. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.30% of the company’s stock.
Several large investors have recently made changes to their positions in AMSG. Norges Bank acquired a new position in shares of Amsurg Corp. during the fourth quarter worth $51,788,000. Capital Growth Management LP acquired a new position in shares of Amsurg Corp. during the second quarter worth $42,647,000. JPMorgan Chase & Co. increased its position in shares of Amsurg Corp. by 213.0% in the first quarter. JPMorgan Chase & Co. now owns 802,101 shares of the company’s stock worth $59,836,000 after buying an additional 545,833 shares in the last quarter. Bank of Montreal Can acquired a new position in shares of Amsurg Corp. during the second quarter worth $36,148,000. Finally, Goldman Sachs Group Inc. increased its position in shares of Amsurg Corp. by 33.5% in the first quarter. Goldman Sachs Group Inc. now owns 1,028,828 shares of the company’s stock worth $76,751,000 after buying an additional 257,891 shares in the last quarter. 98.42% of the stock is currently owned by institutional investors.
About Amsurg Corp.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.